However, its clinical application must be approached with a critical and nuanced understanding of the current evidence gap
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
However, some patients may react to other components in the injection formulation
Human safety data is limited BPC-157 has not been through large controlled trials, so its long-term safety profile is not established the way it is for an approved drug
That is the strength
Inflammation, circulation, oxidative stress, and barrier damage all contribute to poor hair quality and thinning